A study sheds light on how networks in the brain detect new information, offering insight into disorders like schizophrenia.

Findings suggest a safe, inexpensive, and effective pathway for allergists to treat children who already tolerate at least half a peanut

Eating gradually increasing doses of store-bought, home-measured peanut butter for about 18 months enabled 100% of children with peanut allergy who initially could tolerate the equivalent of at least half a peanut to consume three tablespoons of peanut butter without an allergic reaction, researchers report. This easy-to-implement treatment strategy could potentially fulfill an unmet need for about half of children with peanut allergy, who already can tolerate the equivalent of at least half a peanut, considered a high threshold. The findings come from a trial sponsored and funded by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and published today in the journal NEJM Evidence.

A University of Cincinnati study, funded by a $445,000 Eunice Kennedy Shriver National Institute of Child Health and Human Development grant, is examining how exactly patients develop post-stroke sensory reweighting during the first six months after stroke.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms that litter the brain, cerebrospinal fluid and potentially blood, new research published today in Nature Medicine suggests.